Wednesday, April 06, 2022 12:40:03 PM
Which Healthcare Giant Could Deliver Better Returns in 2022?
Source: TipRanks
The COVID-19 pandemic has heightened the focus on healthcare systems, with governments across the globe allocating significant budgets toward drug development and medical facilities. Per the Centers for Medicare & Medicaid Services (CMS), U.S. healthcare spending increased 9.7% to $4.1 trillion in 2020, mainly due to the pandemic. Though the growth rate in national health spending slowed down to 4.2% in 2021, it’s worth noting that this growth was still off the exceptionally high base seen in 2020.
https://www.tipranks.com/news/article/which-healthcare-giant-could-deliver-better-returns-in-2022?utm_source=advfn.com&utm_medium=referral
BNTX $$$$
Source: TipRanks
The COVID-19 pandemic has heightened the focus on healthcare systems, with governments across the globe allocating significant budgets toward drug development and medical facilities. Per the Centers for Medicare & Medicaid Services (CMS), U.S. healthcare spending increased 9.7% to $4.1 trillion in 2020, mainly due to the pandemic. Though the growth rate in national health spending slowed down to 4.2% in 2021, it’s worth noting that this growth was still off the exceptionally high base seen in 2020.
https://www.tipranks.com/news/article/which-healthcare-giant-could-deliver-better-returns-in-2022?utm_source=advfn.com&utm_medium=referral
BNTX $$$$
Recent BNTX News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/22/2026 12:03:17 PM
- BioNTech to Showcase Progress Across Late-Stage Oncology Pipeline at the 2026 ASCO Annual Meeting • GlobeNewswire Inc. • 05/22/2026 09:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/15/2026 08:18:28 PM
- BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2026 • GlobeNewswire Inc. • 05/15/2026 08:15:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 08:04:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:09:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:07:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:05:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:03:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2026 08:02:10 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/12/2026 10:56:54 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/07/2026 12:20:03 PM
- BioNTech Announces New ADS Repurchase Program • GlobeNewswire Inc. • 05/07/2026 10:45:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/05/2026 10:49:47 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/05/2026 10:47:32 AM
- BioNTech Announces First Quarter 2026 Financial Results and Corporate Update • GlobeNewswire Inc. • 05/05/2026 10:45:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/23/2026 08:02:44 PM
- BioNTech to Report First Quarter 2026 Financial Results and Corporate Update on May 5, 2026 • GlobeNewswire Inc. • 04/21/2026 10:45:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/13/2026 11:55:50 AM
- BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer • GlobeNewswire Inc. • 04/11/2026 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/02/2026 08:15:44 PM
- Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 04/01/2026 08:16:07 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2026 10:04:48 PM
